Australian Specialized REITs Stock News

PEXA Group (ASX:PXA) has told investors it plans to exit its majority-owned digital solutions businesses. The move reshapes the group around its core property settlements platform and raises fresh questions about future capital allocation. See our latest analysis for PEXA Group. PEXA Group's latest move comes after a period of steady gains, with a 1-year total shareholder return of 24.19% and an 8.43% year to date share price return at A$14.53, suggesting momentum has been gradually...

JB Hi-Fi (ASX:JBH) has kicked off H1 2026 with A$6.1b in revenue and basic EPS of A$2.80, setting the tone for its latest earnings update. The company has seen revenue move from A$5.7b and EPS of A$2.61 in H1 2025 to A$4.9b and A$1.62 in H2 2025, before reaching A$6.1b and A$2.80 in H1 2026. This gives investors a clear view of how sales and EPS have tracked across recent halves. With a trailing net profit margin of 4.4% and steady earnings over the last twelve months, the story now turns to...

BlueScope Steel (ASX:BSL) has kicked off FY26 with H1 revenue of A$8.3b and basic EPS of A$0.88, as investors weigh these headline numbers against a year where margins have come under pressure. The company has seen revenue move from A$7.9b in H1 2025 to A$8.3b in H1 2026, while basic EPS has shifted from A$0.40 to A$0.88 over the same period. This has occurred against a backdrop of modest 3.4% revenue growth, compressed net profit margins at 1.7%, and a large one off loss that dragged on...

Whitefield Income (ASX:WHI) has released its H1 2026 scorecard, with investors watching how the latest A$16.97 million in trailing twelve month revenue and A$13.39 million in net income feed through to EPS of A$0.159634 on a A$1.425 share price. The company has reported revenue of A$2.04 million and EPS of A$0.058984 in H1 2025, followed by A$8.22 million in revenue and EPS of A$0.04039 in H2 2025, contributing to a reported earnings jump of roughly 8x over the past year and a net profit...

Clarity Pharmaceuticals (ASX:CU6) is back in focus after announcing that an abstract on its dual targeting Co-PSMA agent has been accepted for oral presentation at the EAU Congress 2026, highlighting progress across multiple prostate cancer imaging trials. See our latest analysis for Clarity Pharmaceuticals. The EAU abstract sits alongside a strong run of short term momentum, with a 7 day share price return of 9.48% and a 30 day share price return of 7.83%. However, the year to date share...

Challenger (ASX:CGF) has kicked off H1 2026 with trailing 12 month revenue of A$2.9 billion and basic EPS of A$0.67, while its most recent reported half year, H2 2025, showed revenue of A$1.1 billion and basic EPS of A$0.17. This sets a clear earnings focused backdrop for the latest update. The company has seen revenue move from A$1.3 billion in H2 2024 to A$1.8 billion in H1 2025 and then A$1.1 billion in H2 2025, with basic EPS shifting over the same halves from A$0.11 to A$0.11 and then...

Stockland (ASX:SGP) has reported H1 2026 revenue of A$1.3b and basic EPS of A$0.12, with trailing twelve month revenue of A$3.5b and EPS of A$0.36. These figures frame the latest numbers against a much stronger full year earnings picture, which includes a large one off gain of A$207.0m that helped push earnings growth to 94.9% over the past year. Over recent halves the group has seen revenue move from A$1.0b and EPS of A$0.10 in H1 2025 to A$2.2b and EPS of A$0.24 in H2 2025. This has set the...

Fiducian Group (ASX:FID) has reported another solid set of numbers for H1 2026, with total revenue for the latest half at A$45.0 million and net income at A$9.9 million, translating to basic EPS of A$0.32. The company’s revenue has moved from A$41.8 million in H2 2024 to A$44.3 million in H1 2025 and A$45.0 million in H2 2025, while basic EPS has gone from A$0.26 to A$0.27 and then A$0.32 over the same periods. This provides investors with a clear view of the company’s recent profitability...

Reliance Worldwide (ASX:RWC) has opened H1 2026 reporting with investors focused on how its latest half stacks up against a recent stretch of softer earnings, with the most recent full half year on record showing revenue of US$638.2 million and basic EPS of US$0.074 in H2 2025, compared with US$656.2 million and US$0.075 in H2 2024. Over the past three reported halves, revenue has moved from US$656.2 million in H2 2024 to US$676.5 million in H1 2025 and then to US$638.2 million in H2 2025,...

Baby Bunting Group (ASX:BBN) opened H1 2026 with H2 2025 revenue of A$267.6 million and basic EPS of A$0.042, capped by trailing 12 month revenue of A$539.0 million and EPS of A$0.056. The company has seen revenue move from A$249.9 million in H2 2024 to A$254.4 million in H1 2025 and A$267.6 million in H2 2025, while basic EPS shifted from a loss of A$0.007 in H2 2024 to A$0.029 in H1 2025 and A$0.042 in H2 2025. This sets up a result where modestly higher margins are front and center for...

Deterra Royalties (ASX:DRR) has put up another solid scorecard for H1 2026, with trailing 12 month revenue of A$272.5 million, net income of A$178.9 million and basic EPS of A$0.34, setting a clear benchmark for how the latest half stacks up. Over the last three reported halves, revenue has moved from A$121.5 million in H2 2024 to A$112.3 million in H1 2025 and A$151.1 million in H2 2025, while basic EPS shifted from A$0.14 to A$0.12 and then A$0.17. This gives investors a concrete read on...

Sims (ASX:SGM) has reported H1 2026 results showing revenue of A$3.8b and a basic EPS loss of A$0.155, setting a mixed tone for the half. The company has seen revenue move from A$3.5b in H1 2024 to A$3.8b in H1 2025, while basic EPS shifted from a profit of A$0.510 to a loss of A$0.155, putting the focus firmly on how effectively management is controlling costs and protecting margins. See our full analysis for Sims. With the headline numbers on the table, the next step is to see how this...

Smart Parking (ASX:SPZ) has released its H1 2026 scorecard, with the latest trailing twelve month numbers showing revenue of A$108.1 million and basic EPS of A$0.0142 supported by net income of A$5.8 million. The company has reported revenue of A$27.98 million in H2 2024, A$32.01 million in H1 2025 and A$45.33 million in H2 2025, while basic EPS over those periods came in at A$0.0040, A$0.0112 and A$0.0038 respectively. This provides the backdrop for investors to focus closely on how margins...

Macmahon Holdings (ASX:MAH) has put up another solid set of numbers for H1 2026, with revenue of about A$1.25b and basic EPS of A$0.0206, backed by trailing 12 month revenue of roughly A$2.55b and EPS of A$0.0431 that reflects a 97.2% lift in earnings over the prior year. The company has seen revenue move from A$1.06b in H2 2024 to A$1.18b in H1 2025 and then to A$1.25b in H2 2025, while basic EPS progressed from A$0.0079 to A$0.0141 and then A$0.0206 over the same halves. This sets up a...

MLG Oz (ASX:MLG) has opened H1 2026 reporting season with A$275.4 million in revenue and basic EPS of A$0.054, while trailing 12 month figures show revenue of A$562.7 million and EPS of A$0.100. The company has seen revenue move from A$248.5 million in H2 2024 to A$272.9 million in H1 2025 and A$275.4 million in H2 2025, alongside EPS progressing from A$0.026 to A$0.028 and then A$0.054. This sets up a story where accelerating earnings and modestly shifting margins are front of mind for...

Australian Clinical Labs (ASX:ACL) has just posted its H1 2026 numbers, with revenue of A$365.4 million and net income of A$5.6 million translating to basic EPS of A$0.03, setting a measured tone for the half. The company has seen revenue sit in a tight band over the last year, moving from A$369.2 million in H1 2025 to A$372.1 million in H2 2025 and now A$365.4 million, while EPS has changed from A$0.06 in H1 2025 to A$0.12 in H2 2025 and A$0.03 in the latest half, leaving investors focused...

BHP Group (ASX:BHP) has put fresh numbers on the table for H1 2026, with total revenue of US$26.1 billion and basic EPS of US$0.91, alongside net income of US$4.6 billion. The company has seen recent revenue move from US$28.4 billion in H2 2024 to US$25.2 billion in H1 2025 and US$26.1 billion in H2 2025, while EPS shifted from US$1.38 to US$0.87 and then US$0.91 over the same halves. This sets a clear backdrop for how you read this latest print. With margins easing over the past year, the...

SRG Global (ASX:SRG) has put fresh numbers on the board for H1 2026, with total revenue of A$703.9 million and basic EPS of A$0.047, building on net income of A$28.5 million for the half. The company has seen revenue move from A$558.9 million in H2 2024 to A$620.7 million in H1 2025 and A$703.9 million in H2 2025, while basic EPS stepped from A$0.0368 to A$0.0328 and then A$0.047 across those same periods, and trailing twelve month net income reached A$55.2 million on A$1.4 billion of...

Qualitas (ASX:QAL) has put up another solid set of numbers for H1 2026, with revenue of A$59.9 million and basic EPS of A$0.0585 helping underpin trailing 12 month EPS of A$0.1292 on revenue of A$123.2 million. The company has seen revenue move from A$50.9 million in H2 2024 to A$57.5 million in H1 2025 and A$59.9 million in H2 2025, while basic EPS has tracked from A$0.0471 to A$0.0559 and A$0.0585 over the same periods, setting up trailing net income of A$37.9 million. With net profit...

In February 2026, global markets are navigating a landscape marked by concerns over AI disruption, robust U.S. job gains that have tempered rate cut expectations, and mixed performances across major indices. While the S&P 600 for small-cap stocks has faced its share of volatility amid these broader market shifts, opportunities may still exist for discerning investors who focus on companies with solid fundamentals and active insider participation.

Abacus Storage King (ASX:ASK) has put fresh numbers on the table for H1 2026, with revenue of A$122.4 million, net income of A$71.1 million and basic EPS of A$0.054, while FFO landed at A$41.0 million or A$0.031 per share. Over the recent half year periods, the company has seen revenue move from A$118.7 million in H1 2025 to A$128.2 million in H2 2025, alongside EPS shifting from A$0.0516 to A$0.1684 before settling at the latest H1 2026 print. With FFO and EPS telling slightly different...

Cochlear (ASX:COH) is back in focus after its half year result showed net income of A$161.5 million and a lower full year profit outlook, alongside contracting delays for the new Nucleus Nexa system. See our latest analysis for Cochlear. The sharp post earnings selloff has left Cochlear at a share price of A$199.81, with a 7 day share price return of 22.22% and a 1 year total shareholder return of 25.96%. This signals fading momentum as investors reassess risks around Nexa adoption and the...

Vita Life Sciences FY 2025 Earnings Snapshot Vita Life Sciences (ASX:VLS) has reported its FY 2025 first half with revenue of A$45.5 million and basic EPS of A$0.086, setting the tone for a year that also saw trailing twelve month revenue reach A$93.3 million and EPS of A$0.186. Over the last few reporting periods the company has seen revenue move from A$39.5 million in 1H FY 2024 to A$40.1 million in 2H FY 2024 and then to A$45.5 million in 1H FY 2025. Over the same periods, basic EPS...

Judo Capital Holdings Limited has released its half-year results for the period ended 31 December 2025, reporting net interest income of A$235.5 million and net income of A$59.9 million, both higher than the same period a year earlier. The uplift in basic earnings per share from continuing operations to A$0.054 highlights how higher income is increasingly flowing through to shareholders’ bottom-line results. We’ll now examine how this earnings uplift, particularly the rise in net interest...